Samir Ounzain, Haya CEO
A new RNA startup looks to reimagine heart treatments, with eyes set on Entresto
When Samir Ounzian left London a decade ago to study a little-understood branch of the genome at a Swiss lab, he wasn’t sure what he …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
